Skip to main content

Table 4 Treatment success in both groups

From: Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff

Efficacy Parameter

VB-001 (N = 78)

ZPTO shampoo (N = 81)

P value

Mean ASFS (normalized) difference (Baseline-Day 14)

75.6%

67.9%

0.0005a

Mean pruritus score (normalized) difference (Baseline-Day 9)

75%

61%

0.03a

Mean scalp related quality of life index score difference (Baseline-Day 14)

51.6%

45.1%

0.03b

Visible hair fall reduction at day 14 (% of subjects)

41%

18.5%

<0.05c

Softness at day 14 (% of subjects)

83.3%

67.9%

<0.05c

  1. aSignificant by t-test; bSignificant by ANOVA Kruskal Wallis; cSignificant by Chi square test